Open-Label, phase 2 study of blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
暂无分享,去创建一个
G. Verhoef | J. Franklin | K. Mason | A. Rambaldi | D. Cohan | C. Furness | L. Coyle | A. S. Jung | A. Zhang | N. Morley